Ziad Omran

2.0k total citations · 1 hit paper
46 papers, 1.5k citations indexed

About

Ziad Omran is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Ziad Omran has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 9 papers in Organic Chemistry and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Ziad Omran's work include Photoreceptor and optogenetics research (4 papers), Surfactants and Colloidal Systems (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Ziad Omran is often cited by papers focused on Photoreceptor and optogenetics research (4 papers), Surfactants and Colloidal Systems (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). Ziad Omran collaborates with scholars based in Saudi Arabia, France and United Kingdom. Ziad Omran's co-authors include Nicolas Anton, Thierry Vandamme, Mohamed F. Attia, Justine Wallyn, Alexandre Specht, Cyril Rauch, Mahmoud Alhosin, Donald Cairns, Christian Bronner and Mazin A. Zamzami and has published in prestigious journals such as Journal of Molecular Biology, Langmuir and International Journal of Molecular Sciences.

In The Last Decade

Ziad Omran

44 papers receiving 1.5k citations

Hit Papers

An overview of active and passive targeting strategies to... 2019 2026 2021 2023 2019 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziad Omran Saudi Arabia 17 650 459 459 263 127 46 1.5k
Gantumur Battogtokh South Korea 16 490 0.8× 312 0.7× 410 0.9× 198 0.8× 162 1.3× 31 1.1k
Gigi Ngar Chee Chiu Singapore 20 616 0.9× 650 1.4× 439 1.0× 201 0.8× 120 0.9× 32 1.4k
Bin Du China 21 358 0.6× 334 0.7× 527 1.1× 286 1.1× 76 0.6× 82 1.2k
Sudipta Basu India 23 732 1.1× 375 0.8× 421 0.9× 349 1.3× 175 1.4× 75 1.7k
Bakheet Elsadek Egypt 18 850 1.3× 428 0.9× 255 0.6× 196 0.7× 319 2.5× 37 1.7k
Zhiyu Qian China 21 418 0.6× 274 0.6× 465 1.0× 598 2.3× 228 1.8× 46 1.4k
Qicai Xiao China 20 681 1.0× 522 1.1× 952 2.1× 423 1.6× 106 0.8× 39 1.9k
Caoyun Ju China 21 653 1.0× 588 1.3× 512 1.1× 134 0.5× 230 1.8× 38 1.5k
Jinha Yu South Korea 22 764 1.2× 264 0.6× 258 0.6× 429 1.6× 193 1.5× 61 1.9k
Kaiyan Lou United States 19 626 1.0× 432 0.9× 260 0.6× 140 0.5× 51 0.4× 30 1.3k

Countries citing papers authored by Ziad Omran

Since Specialization
Citations

This map shows the geographic impact of Ziad Omran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziad Omran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziad Omran more than expected).

Fields of papers citing papers by Ziad Omran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziad Omran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziad Omran. The network helps show where Ziad Omran may publish in the future.

Co-authorship network of co-authors of Ziad Omran

This figure shows the co-authorship network connecting the top 25 collaborators of Ziad Omran. A scholar is included among the top collaborators of Ziad Omran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziad Omran. Ziad Omran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omran, Ziad, et al.. (2024). Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy. International Journal of Molecular Sciences. 25(20). 11293–11293. 3 indexed citations
2.
Kaleem, Mohammed, Ryan A. Sheikh, Mohammed Hassan, et al.. (2024). In Vitro and In Vivo Preventive Effects of Thymoquinone against Breast Cancer: Role of DNMT1. Molecules. 29(2). 434–434. 10 indexed citations
3.
Sheikh, Ryan A., Hisham N. Altayb, Salman Hosawi, et al.. (2022). The Potential Role of Nigella sativa Seed Oil as Epigenetic Therapy of Cancer. Molecules. 27(9). 2779–2779. 13 indexed citations
4.
Wang, Xinyue, Mayeul Collot, Ziad Omran, et al.. (2020). Further insights into release mechanisms from nano-emulsions, assessed by a simple fluorescence-based method. Journal of Colloid and Interface Science. 578. 768–778. 10 indexed citations
5.
Omran, Ziad, et al.. (2020). <p>Repurposing Disulfiram as an Anti-Obesity Drug: Treating and Preventing Obesity in High-Fat-Fed Rats</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 1473–1480. 18 indexed citations
6.
Papin, Christophe, Stéphanie Le Gras, Abdulkhaleg Ibrahim, et al.. (2020). CpG Islands Shape the Epigenome Landscape. Journal of Molecular Biology. 433(6). 166659–166659. 14 indexed citations
7.
Omran, Ziad, et al.. (2020). Pickering nano-emulsions stabilized by Eudragit RL100 nanoparticles as oral drug delivery system for poorly soluble drugs. Colloids and Surfaces B Biointerfaces. 191. 111010–111010. 19 indexed citations
8.
Rehman, Asad Ur, Ziad Omran, Halina Anton, et al.. (2018). Development of doxorubicin hydrochloride loaded pH-sensitive liposomes: Investigation on the impact of chemical nature of lipids and liposome composition on pH-sensitivity. European Journal of Pharmaceutics and Biopharmaceutics. 133. 331–338. 54 indexed citations
9.
Omran, Ziad, Paula J. Scaife, Simon Stewart, & Cyril Rauch. (2017). Physical and biological characteristics of multi drug resistance (MDR): An integral approach considering pH and drug resistance in cancer. Seminars in Cancer Biology. 43. 42–48. 30 indexed citations
10.
Alhosin, Mahmoud, Ziad Omran, Mazin A. Zamzami, et al.. (2016). Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 174–174. 85 indexed citations
11.
Omran, Ziad. (2016). Obesity: Current Treatment and Future Horizons. Mini-Reviews in Medicinal Chemistry. 17(1). 51–61. 7 indexed citations
12.
Fais, Stefano, Enrico P. Spugnini, Salvador Harguindey, et al.. (2015). Proton pump inhibitors for the treatment of cancer in companion animals. Journal of Experimental & Clinical Cancer Research. 34(1). 93–93. 31 indexed citations
13.
Omran, Ziad & Cyril Rauch. (2014). Acid-mediated Lipinski’s second rule: application to drug design and targeting in cancer. European Biophysics Journal. 43(4-5). 199–206. 25 indexed citations
15.
Chahrour, Osama, Donald Cairns, & Ziad Omran. (2012). Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics. Mini-Reviews in Medicinal Chemistry. 12(5). 399–411. 44 indexed citations
16.
Malmerberg, Erik, Ziad Omran, Jochen S. Hub, et al.. (2011). Time-Resolved WAXS Reveals Accelerated Conformational Changes in Iodoretinal-Substituted Proteorhodopsin. Biophysical Journal. 101(6). 1345–1353. 59 indexed citations
17.
Omran, Ziad, et al.. (2011). Synthesis and in vitro evaluation of novel pro-drugs for the treatment of nephropathic cystinosis. Bioorganic & Medicinal Chemistry. 19(11). 3492–3496. 9 indexed citations
18.
Omran, Ziad, et al.. (2011). Folate pro-drug of cystamine as an enhanced treatment for nephropathic cystinosis. Bioorganic & Medicinal Chemistry Letters. 21(8). 2502–2504. 11 indexed citations
19.
Specht, Alexandre, Frédéric Bolze, Ziad Omran, Jean‐François Nicoud, & Maurice Goeldner. (2009). Photochemical tools to study dynamic biological processes. PubMed. 3(4). 255–264. 70 indexed citations
20.
Omran, Ziad, Thomas Cailly, Jana Sopková‐de Oliveira Santos, et al.. (2005). Synthesis and biological evaluation as AChE inhibitors of new indanones and thiaindanones related to donepezil. European Journal of Medicinal Chemistry. 40(12). 1222–1245. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026